Correlation Engine 2.0
Clear Search sequence regions


  • antibodies (1)
  • fibroblasts (1)
  • macrophages (1)
  • phases (1)
  • progress tumor (1)
  • research (2)
  • t (1)
  • treg cells (1)
  • Sizes of these terms reflect their relevance to your search.

    Compared with traditional cancer treatment methods, tumor-targeted immunotherapy can combine targeted therapy and immunotherapy with long-lasting responses to achieve synergistic therapy, which brings hope to the complete cure of cancer. This review summarizes the newest and most up-to-date advances in tumor-targeted immunotherapy, including tumor-associated macrophages (TAMs) targeted immunotherapy, regulatory T (Treg) cells targeted immunotherapy, tumor-associated fibroblasts (TAFs) targeted immunotherapy and immune checkpoints targeted immunotherapy. Immunotherapy can restore anti-tumor immunity in the tumor microenvironment and produce a lasting immune surveillance effect. Smart multifunctional nano delivery system can effectively combine targeted therapy with immunotherapy, which has attracted extensive attention. With the deepening of research, more and more tumor-targeted immunotherapy enter into the clinical trial phases, especially antibodies and inhibitors. Tumor-targeted immunotherapy is a promising approach for conquering cancer and bringing hope for human health.

    Citation

    Yuelin Fang, Aihua Yu, Lei Ye, Guangxi Zhai. Research progress in tumor targeted immunotherapy. Expert opinion on drug delivery. 2021 Apr 14:1-23


    PMID: 33507117

    View Full Text